chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) started maintenance HD therapy using a forearm autogenous radio-cephalic AVF during 1997-2008 at Nagoya City University Hospital,2) the AVF was constructed at Nagoya City University Hospital, and 3) age 20 years or more at initiation of HD, regardless of gender.
Exclusion criteria
Exclusion criteria: 1) acute kidney injuries or rapidly progressive glomerulonephritis, 2) coronary or cerebrovascular events within the previous 6 months before initiation of HD, 3) serious systemic diseases, and 4) starting HD using a wrist (tabatiere region) AVF, AVG, silastic cannula external arteriovenous shunt, and temporary or long-term CVC.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint was the first occurrence of a VA event, which was defined as the composite of thrombectomy, surgical revision, or percutaneous transluminal angioplasty (PTA). | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional primary patency | — |
Countries
Japan
Contacts
Nagoya City University Graduate school of Medical Sciences Division of Nephrology, Dialysis Center